Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
StepStone Group to Announce Fourth Quarter and Fiscal 2026 Results on May 20, 2026
-
Applied Materials to Participate in Upcoming Investor Conferences
-
Abaxx Signs MoU to Support Development of Cambodian National Futures Exchange
-
Quantum Leap Energy Appoints Dr. Peter Fiske to Strategic Advisory Board
-
Stillwater Critical Minerals to Present at the Precious Metals & Critical Minerals Virtual Investor Conference May 7th
-
Award-Winning Habit Celebrates Newest Restaurant Launch in Eureka, California
-
Altimmune to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026
-
VenHub Highlights Rapid Progress Since Nasdaq Debut Including Expanded Smart Store Deployments, Enhanced Technology Platform and Increased Las Vegas Production Capacity
-
BEYONTTRA™ (acoramidis), the First Near-Complete TTR Stabilizer (≥90%), Approved by ANVISA to Treat ATTR-CM in Brazil
-
Immusoft to Present Data Highlighting Positive Results from the World’s First Engineered B Cell in a Human Clinical Trial at ASGCT 2026
-
Kura Oncology to Participate in Bank of America Securities Healthcare Conference
-
REalloys (NASDAQ: ALOY) Receives Department of War Memorandum on Securing Domestic Heavy Rare Earth Supply Ahead of 2027 Deadline
-
onsemi Announces Proposed Private Offering of $1.3 Billion of Convertible Senior Notes
-
X4 Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update
-
Anhui uncovered: From historic treasures to tech horizons
-
Nouryon launches first commercially available solution to restore recycled polypropylene performance in packaging, automotive and consumer goods
-
Nouryon launches first commercially available solution to restore recycled polypropylene performance in packaging, automotive and consumer goods
-
Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update
-
Transportation Institute Names Sara Fuentes as President
-
Brink's Delivers Strong First-Quarter Results with Double-Digit Revenue Growth
-
TransAlta Reports First Quarter Results and Reaffirms Annual Guidance
-
Lakeland Capital Expands with Director of Investor Relations Hire
-
GDS to Report First Quarter 2026 Financial Results Before the Open of the U.S. Market on May 20, 2026
-
Astec Reports First Quarter 2026 Results
-
Marex Group plc announces first quarter 2026 results
-
J & J Snack Foods Reports Fiscal 2026 Second Quarter Results
-
Brink's Delivers Strong First-Quarter Results with Double-Digit Revenue Growth
-
Hyperion DeFi Announces Pricing of Public Offering of Common Stock
-
Strata Critical Medical Announces First Quarter 2026 Results
-
Madrigal Pharmaceuticals Reports First-Quarter 2026 Financial Results and Provides Corporate Updates
-
U.S. Energy Corp. Selected to Participate in the Inaugural Emerging Company Pavilion at the 31st Annual Sohn Investment Conference on May 12, 2026
-
Tonix Pharmaceuticals Secures Commercial Payer Coverage for TONMYA®, Providing Access for ~35 Million U.S. Patients
-
OTC Markets Group Welcomes Yangarra Resources Ltd. to OTCQX
-
BioCryst Reports First Quarter 2026 Financial Results and Provides Business Update
-
TG Therapeutics Reports First Quarter 2026 Financial Results and Raises BRIUMVI Revenue Guidance
-
NexGold Intersects 14.10 g/t Gold Over 6.0 Metres, 2.99 g/t Gold over 20.0 Metres and 10.67 g/t Gold Over 7.0 Metres at the Goldlund Deposit, Ontario
-
TScan Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
-
EyePoint Reports First Quarter 2026 Financial Results and Highlights Recent Corporate Developments
-
Kamada to Announce First Quarter 2026 Financial Results on May 13, 2026
-
KVH Industries Reports First Quarter 2026 Results
-
Aquestive Therapeutics to Report First Quarter 2026 Financial Results and Recent Business Highlights on May 13 and Host Conference Call on May 14 at 8:00 a.m. ET
-
Advantage Solutions Reports First Quarter 2026 Results
-
Eupraxia Pharmaceuticals’ First Release of EoEHSS Sub Scores Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week
-
Climb Announces North American Distribution Partnership with Dashlane
-
Immunocore reports first quarter financial results and provides a business update
-
Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer
-
Perma-Fix Reports First Quarter 2026 Results and Strategic Outlook
-
Sprott Announces First Quarter 2026 Results
-
Tempest Presents Clinical Update at ISCT 2026 Annual Meeting
-
Geron Corporation Reports First Quarter 2026 Financial Results and Recent Business Highlights

